Showing results (21-30 of 74) with videos related to
Sort By:
Pageof 8
International Journal of Clinical Pharmacology and Therapeutics|September 20, 2016
The efficacy of febuxostat 10 mg for the prevention of hyperuricemia associated with tumor lysis syndrome (TLS) in Japanese patients with non-Hodgkin's lymphomaTakeo Yasu, Shunsuke Kobayashi, Mai Horii, et al.Chemotherapy|June 16, 2024
Successful Isavuconazole Treatment for Pulmonary Mucormycosis in a Patient Intolerant to Liposomal Amphotericin B with Pharmacokinetic Insights: A Case ReportTakeo Yasu, Makoto Hoshino, Naoya Sakamoto, et al.BMJ Case Reports|January 3, 2025
Cholestasis due to biliary obstruction can cause cardiogenic shock with bradycardia by delaying the elimination of arotinololYuki Iizuka, Yasunori Urayama, Takeo Yasu, et al.Medical Oncology (Northwood, London, England)|October 12, 2022
Utility of therapeutic drug monitoring of venetoclax in acute myeloid leukemiaMasayuki Kobayashi, Takeo Yasu, Ken Suzaki, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 20, 2009
[A case of therapy for bevacizumab-induced hypertension]Takeo Yasu, Yoshiyuki Miyasaka, Hideo Chubachi, et al.International Journal of Clinical Pharmacology and Therapeutics|January 28, 2020
Potential thiamine deficiency in elderly patients with gastrointestinal cancer undergoing chemotherapyTakeo Yasu, Yohei Iimura, Kenji Momo, et al.Biomedical Chromatography : BMC|March 17, 2025
High-Performance Liquid Chromatography-Ultraviolet Assay for the Determination of Pirtobrutinib Levels in a Patient With Mantle Cell LymphomaYoshito Gando, Takeo Yasu, Mari Shimoda, et al.Cancer Chemotherapy and Pharmacology|December 7, 2024
Pharmacokinetic analysis of crushed venetoclax tablets combined with azacitizine for recurrent pediatric acute myeloid leukemia (AML)Motohiro Matsui, Takeo Yasu, Atsushi Makimoto, et al.Drug Discoveries & Therapeutics|June 21, 2026
Analytical method validation and feasibility of salivary pregabalin measurement in Japanese volunteers: A pilot studyHina Itoi, Yoshito Gando, Takeo Yasu, et al.Journal of Clinical Pharmacy and Therapeutics|May 8, 2019
Risk factors affecting the failed low-density lipoprotein level achievement rate in working-age male population at high cardiovascular riskKenji Momo, Takeo Yasu, Hiroshi Yasui, et al.Pageof 8